← FDA DRUG APPROVALS

FDA NDA · NDA009900

CORTEF

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
NDA009900
TYPE
NDA
ORIGINAL APPROVAL
1955-05-10
LATEST ACTION
1997-12-01
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

CORTEFDiscontinued
HYDROCORTISONE CYPIONATE EQ 10MG BASE/5ML · SUSPENSION · ORAL

Approval history

1997-12-01Manufacturing (CMC) · Supplement 27 · standardAP
1993-12-28Labeling · Supplement 23AP
1990-08-29Manufacturing (CMC) · Supplement 22 · standardAP
1982-06-30Manufacturing (CMC) · Supplement 18 · standardAP
1979-06-04Labeling · Supplement 16AP
1955-05-10Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →